New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareHexarelin vs AHK-Cu

Hexarelin vs AHK-Cu

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
Hexarelin
Skin & CosmeticAnti-Aging & Longevity
AHK-Cu
Summary
Hexarelin is a potent synthetic GHRP and the strongest GH secretagogue in its class per unit dose. It also exhibits unique cardioprotective properties through direct binding to cardiac CD36 receptors, independent of GH release. Its potency is balanced by a tendency to desensitize GH release with prolonged use, making cycling important.
AHK-Cu is a copper tripeptide composed of alanine, histidine, and lysine chelated to copper. Distinct from GHK-Cu, AHK-Cu exhibits strong affinity for hair follicle receptors and demonstrates potent hair growth stimulation alongside wound healing and skin regeneration properties.
Half-Life
~70 minutes
Hours (topical, variable by formulation)
Admin Route
SubQ
Topical, Scalp application, Subcutaneous (research)
Research
Typical Dose
100–200 mcg
0.01–0.1% concentration
Frequency
2–3 times daily
Once or twice daily
Key Benefits
  • Strongest GH pulse per mcg among GHRPs
  • Unique direct cardioprotective effects via CD36
  • Increased IGF-1 and muscle anabolism
  • Accelerated recovery from training
  • Bone density support
  • Anti-aging via GH axis
  • Potential cardiac rehabilitation benefits
  • Stimulates hair follicle growth and reduces shedding
  • Increases dermal papilla cell proliferation
  • Promotes wound healing and skin regeneration
  • Antioxidant protection via superoxide dismutase activation
  • Improves skin elasticity and firmness
  • Supports collagen and elastin production
Side Effects
  • Water retention
  • Elevated cortisol
  • Elevated prolactin (more pronounced than other GHRPs)
  • Receptor desensitization with continuous use
  • +1 more
  • Generally well-tolerated topically
  • Mild scalp irritation or redness in sensitive individuals
  • Possible temporary hair shedding phase at treatment initiation
  • Copper accumulation with excessive systemic use (rare)
Stacks With